Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | ADH1B | P00325 | 1/20 | 0.34 |
| ▸ | ADH1C | P00326 | 1/20 | 0.34 |
| ▸ | ADH1A | P07327 | 1/20 | 0.34 |
| ▸ | ADH4 | P08319 | 1/20 | 0.34 |
| ▸ | ADH7 | P40394 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | FDPS | P14324 | 2/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.33 |
| ▸ | GAPDH | P04406 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9015898 | 0.97 | TSHR (0.46) | TSHRSMN1; SMN2DNM1OPRM1ALDH1A1 | |
| SCHEMBL9015991 | 0.95 | DNM1 (0.46) | TSHRSMN1; SMN2DNM1OPRM1LMNA | |
| SCHEMBL10899262 | 0.95 | DNM1 (0.46) | TSHRSMN1; SMN2DNM1OPRM1LMNA | |
| SCHEMBL25171286 | 0.95 | DNM1 (0.46) | TSHRSMN1; SMN2DNM1OPRM1LMNA | |
| SCHEMBL9015831 | 0.95 | DNM1 (0.46) | TSHRSMN1; SMN2DNM1OPRM1LMNA | |
| SCHEMBL25178155 | 0.95 | DNM1 (0.46) | TSHRSMN1; SMN2DNM1OPRM1LMNA | |
| SCHEMBL9724790 | 0.95 | TSHR (0.42) | TSHRSMN1; SMN2DNM1OPRM1ALDH1A1 | |
| SCHEMBL25172438 | 0.92 | TSHR (0.46) | TSHRSMN1; SMN2DNM1OPRM1ALDH1A1 | |
| SCHEMBL25182453 | 0.92 | TSHR (0.46) | TSHRSMN1; SMN2DNM1OPRM1ALDH1A1 | |
| SCHEMBL25181774 | 0.92 | TSHR (0.46) | TSHRSMN1; SMN2DNM1OPRM1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1167372-B1 | 2,2-(Diaryl)vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | TAKASAGO PERFUMERY CO LTD (JP) | 2003-12-10 | — | — | EP | claimed |
| US-6455720-B1 | AS CATALYSTS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-09-24 | — | — | US | claimed |
| US-20020058837-A1 | 2,2 (Diarlyl) Vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-05-16 | — | — | US | claimed |
| EP-1167372-A1 | 2,2-(Diaryl)vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | Takasago International Corporation (JP) | 2002-01-02 | — | — | EP | claimed |
| US-9126892-B2 | Blue fluorescence compound and organic electroluminescence device using the same | LG DISPLAY CO., LTD. (KR) | 2015-09-08 | — | — | US | disclosed |
| US-20120305894-A1 | BLUE PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | LG DISPLAY CO., LTD (KR) | 2012-12-06 | — | — | US | disclosed |
| US-20110156011-A1 | BLUE FLUORESCENCE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | LG DISPLAY CO., LTD. (KR) | 2011-06-30 | — | — | US | disclosed |
| US-7846558-B2 | Blue light emitting compound and organic electroluminescent device using the same | SFC CO., LTD. (KR) | 2010-12-07 | — | — | US | disclosed |
| US-20080203905-A1 | Blue light emitting compound and organic electroluminescent device using the same | SFC CO., LTD. (KR) | 2008-08-28 | — | — | US | disclosed |
| EP-1167372-B1 | 2,2-(Diaryl)vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | TAKASAGO PERFUMERY CO LTD (JP) | 2003-12-10 | — | — | EP | disclosed |
| EP-1167372-B1 | 2,2-(Diaryl)vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | TAKASAGO PERFUMERY CO LTD (JP) | 2003-12-10 | — | — | EP | disclosed |
| US-6455720-B1 | AS CATALYSTS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-09-24 | — | — | US | disclosed |
| US-6455720-B1 | AS CATALYSTS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-09-24 | — | — | US | disclosed |
| JP-2002187894-A | 2,2-(DIARYL)VINYLPHOSPHINE COMPOUND, ITS PALLADIUM CATALYST AND METHOD FOR PRODUCING ARYLAMINE, DIARYL AND ARYLALKYNE USING THE CATALYST | TAKASAGO INTERNATL CORP | 2002-07-05 | — | — | JP | disclosed |
| US-20020058837-A1 | 2,2 (Diarlyl) Vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-05-16 | — | — | US | disclosed |
| US-20020058837-A1 | 2,2 (Diarlyl) Vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-05-16 | — | — | US | disclosed |
| EP-1167372-A1 | 2,2-(Diaryl)vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | Takasago International Corporation (JP) | 2002-01-02 | — | — | EP | disclosed |
| EP-1167372-A1 | 2,2-(Diaryl)vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | Takasago International Corporation (JP) | 2002-01-02 | — | — | EP | disclosed |
| EP-1167372-A1 | 2,2-(Diaryl)vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | Takasago International Corporation (JP) | 2002-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020058837-A1 | 2,2 (Diarlyl) Vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | DDT, PDCD11, PLD2 | TSHR 2225/4885SMN1; SMN2 4274/4885DNM1 427/4885 |
| US-20120305894-A1 | BLUE PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | C5, CLIC1, CLIC4 | TSHR 1832/4885SMN1; SMN2 4029/4885DNM1 4496/4885 |
| US-20080203905-A1 | Blue light emitting compound and organic electroluminescent device using the same | TYR, CYBA, CRY2 | TSHR 4291/4885SMN1; SMN2 2463/4885DNM1 3881/4885 |
| US-20110156011-A1 | BLUE FLUORESCENCE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | KCNN2, ORAI2, ETV6 | TSHR 4621/4885SMN1; SMN2 3722/4885DNM1 2033/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.